首页> 外文期刊>European Journal of Radiology >MRI evaluation of a new scaffold-based allogenic chondrocyte implantation for cartilage repair.
【24h】

MRI evaluation of a new scaffold-based allogenic chondrocyte implantation for cartilage repair.

机译:新型基于支架的同种异体软骨细胞植入物用于软骨修复的MRI评估。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: The present study was designed to evaluate the implantation of alginate beads containing human mature allogenic chondrocytes for the treatment of symptomatic cartilage defects of the knee. MRI was used for the morphological analysis of cartilage repair. The correlation between MRI findings and clinical outcome was also studied. METHODS: A biodegradable, alginate-based biocompatible scaffold containing human mature allogenic chondrocytes was used for the treatment of symptomatic chondral and osteochondral lesions in the knee. Twenty-one patients were prospectively evaluated with use of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the Visual Analogue Scale (VAS) for pain preoperatively and at 3, 6, 9 and 12 months of follow-up. Of the 21 patients, 12 had consented to follow the postoperative MRI evaluation protocol. MRI data were analyzed based on the original MOCART (Magnetic Resonance Observation of Cartilage Repair Tissue) and modified MOCART scoring system. The correlation between the clinical outcome and MRI findings was evaluated. RESULTS: A statistically significant clinical improvement became apparent after 6 months and patients continued to improve during the 12 months of follow-up. One of the two MRI scoring systems that were used, showed a statistically significant deterioration of the repair tissue at 1 year of follow-up. Twelve months after the operation complete filling or hypertrophy was found in 41.6%. Bone-marrow edema and effusion were seen in 41.7% and 25% of the study patients, respectively. We did not find a consistent correlation between the MRI criteria and the clinical results. DISCUSSION: The present study confirmed the primary role of MRI in the evaluation of cartilage repair. Two MOCART-based scoring systems were used in a longitudinal fashion and allowed a practical and morphological evaluation of the repair tissue. However, the correlation between clinical outcome and MRI findings was poor. Further validation of these scoring systems is mandatory. The promising short-term clinical outcome of the allogenic chondrocytes/alginate beads implantation was not confirmed by the short-term MRI findings.
机译:目的:本研究旨在评估含有人成熟同种异体软骨细胞的藻酸盐微珠的植入情况,以治疗膝部症状性软骨缺损。 MRI用于软骨修复的形态分析。还研究了MRI检查结果与临床结果之间的相关性。方法:使用含有人成熟同种异体软骨细胞的可生物降解的基于藻酸盐的生物相容性支架治疗膝部症状性软骨和骨软骨病变。术前以及术后3、6、9和12个月使用西安大略省和麦克马斯特大学骨关节炎指数(WOMAC)和视觉模拟量表(VAS)对21例患者进行前瞻性评估。在21例患者中,有12例同意遵循术后MRI评估方案。根据原始的MOCART(软骨修复组织的磁共振观察)和改进的MOCART评分系统分析MRI数据。评价了临床结局与MRI表现之间的相关性。结果:6个月后,统计学上显着的临床改善变得明显,并且患者在随访的12个月中持续改善。使用的两个MRI评分系统之一在随访1年时显示出修复组织的统计学显着恶化。手术十二个月后发现完全充盈或肥大的比例为41.6%。 41.7%和25%的患者分别出现了骨髓水肿和积液。我们在MRI标准和临床结果之间没有发现一致的相关性。讨论:本研究证实了MRI在评估软骨修复中的主要作用。纵向使用了两个基于MOCART的评分系统,可以对修复组织进行实用和形态评估。但是,临床结果与MRI表现之间的相关性很差。必须对这些评分系统进行进一步验证。短期MRI结果未证实同种异体软骨细胞/藻酸盐珠植入的有希望的短期临床结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号